Page last updated: 2024-10-28

miltefosine and Thrombocytopenia

miltefosine has been researched along with Thrombocytopenia in 2 studies

miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.

Thrombocytopenia: A subnormal level of BLOOD PLATELETS.

Research Excerpts

ExcerptRelevanceReference
"Sodium antimony gluconate (SAG) and miltefosine used in the treatment of kala-azar are known to cause several side effects but severe thrombocytopenia has not been reported."7.74Pharmacovigilance in kala-azar patients with severe thrombocytopenia caused by sodium antimony gluconate & miltefosine. ( Kumar, A; Mitra, G; Thakur, CP; Thakur, M; Thakur, S, 2007)
"Sodium antimony gluconate (SAG) and miltefosine used in the treatment of kala-azar are known to cause several side effects but severe thrombocytopenia has not been reported."3.74Pharmacovigilance in kala-azar patients with severe thrombocytopenia caused by sodium antimony gluconate & miltefosine. ( Kumar, A; Mitra, G; Thakur, CP; Thakur, M; Thakur, S, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agarwal, PK1
Thakur, CP1
Kumar, A1
Mitra, G1
Thakur, S1
Thakur, M1

Other Studies

2 other studies available for miltefosine and Thrombocytopenia

ArticleYear
Miltefosine for Indian visceral leishmaniasis.
    The New England journal of medicine, 2003, Feb-27, Volume: 348, Issue:9

    Topics: Antiprotozoal Agents; Hemorrhage; HIV Infections; Humans; Leishmaniasis, Visceral; Phosphorylcholine

2003
Pharmacovigilance in kala-azar patients with severe thrombocytopenia caused by sodium antimony gluconate & miltefosine.
    The Indian journal of medical research, 2007, Volume: 126, Issue:1

    Topics: Adolescent; Adult; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Humans; Leishmaniasis, V

2007